Data as of Jan 23
| -0.09 / -1.10%|
The 2 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 21.88, with a high estimate of 25.00 and a low estimate of 18.75. The median estimate represents a +170.73% increase from the last price of 8.08.
The current consensus among 2 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.